Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Apr '25 Apr 2, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
Market Capitalization	17	14	13	14	98	78	Upgrade
Market Cap Growth	-59.72%	8.40%	-6.42%	-85.44%	26.16%	65.89%	Upgrade
Enterprise Value	15	12	7	1	90	75	Upgrade
Last Close Price	2.32	4.45	4.42	6.45	51.66	56.49	Upgrade
Forward PE	-	-	-	56.67	-	-	Upgrade
PS Ratio	-	-	-	-	235.84	Upgrade
PB Ratio	6.27	7.29	1.89	1.52	7.49	8.51	Upgrade
P/TBV Ratio	-	-	2.74	2.00	9.16	18.70	Upgrade
EV/Sales Ratio	-	-	-	-	226.70	Upgrade
Debt / Equity Ratio	-	0.01	0.01	0.00	0.01	0.02	Upgrade
Asset Turnover	-	-	-	-	-	0.04	Upgrade
Quick Ratio	1.01	0.71	3.29	3.90	7.64	4.77	Upgrade
Current Ratio	1.09	0.91	3.53	4.25	8.29	5.30	Upgrade
Return on Equity (ROE)	-150.67%	-136.66%	-101.88%	-156.34%	-120.39%	-88.61%	Upgrade
Return on Assets (ROA)	-73.52%	-69.02%	-56.33%	-87.78%	-116.79%	-48.55%	Upgrade
Return on Capital (ROIC)	-107.73%	-95.89%	-69.64%	-101.75%	-131.97%	-55.07%	Upgrade
Earnings Yield	-36.62%	-42.70%	-62.82%	-123.19%	-13.64%	-8.21%	Upgrade
FCF Yield	-29.98%	-33.84%	-49.78%	-86.24%	-13.98%	-6.44%	Upgrade
Buyback Yield / Dilution	-8.96%	-11.84%	-36.37%	-21.50%	-40.32%	-87.63%	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q